These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 11265647
21. The role of CpG dinucleotides in DNA vaccines. Krieg AM, Yi AK, Schorr J, Davis HL. Trends Microbiol; 1998 Jan; 6(1):23-7. PubMed ID: 9481820 [Abstract] [Full Text] [Related]
23. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory. Mortara L, Castellani P, Meazza R, Tosi G, De Lerma Barbaro A, Procopio FA, Comes A, Zardi L, Ferrini S, Accolla RS. Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3435-43. PubMed ID: 16740768 [Abstract] [Full Text] [Related]
24. MHC class II-mediated antigen presentation by alloreactive rat CD4+ T cells does not induce regulatory properties. Otto C, Heeg A, Kottenmeier S, Tiurbe GC, Thiede A, Ulrichs K. Transplant Proc; 2006 Apr 01; 38(3):755-6. PubMed ID: 16647463 [Abstract] [Full Text] [Related]
25. Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs. Sugauchi F, Wang RY, Qiu Q, Jin B, Alter HJ, Shih JW. J Infect Dis; 2006 Feb 15; 193(4):563-72. PubMed ID: 16425136 [Abstract] [Full Text] [Related]
26. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Arancibia-Cárcamo CV, Osawa H, Arnett HA, Háskova Z, George AJ, Ono SJ, Ting JP, Streilein JW. Eur J Immunol; 2004 Feb 15; 34(2):471-80. PubMed ID: 14768052 [Abstract] [Full Text] [Related]
27. MHC class II antigen expression is not induced on murine epidermal keratinocytes by interferon-gamma alone or in combination with tumour necrosis factor-alpha. Yeoman H, Anderton JG, Stanley MA. Immunology; 1989 Jan 15; 66(1):100-5. PubMed ID: 15493270 [Abstract] [Full Text] [Related]
28. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine. Xu W, Chu Y, Zhang R, Xu H, Wang Y, Xiong S. Virology; 2005 Apr 10; 334(2):255-63. PubMed ID: 15780875 [Abstract] [Full Text] [Related]
29. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells. Diebold SS, Cotten M, Koch N, Zenke M. Gene Ther; 2001 Mar 10; 8(6):487-93. PubMed ID: 11313828 [Abstract] [Full Text] [Related]
30. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule. Hetttihewa LM. Int Immunopharmacol; 2003 Oct 10; 3(10-11):1401-11. PubMed ID: 12946436 [Abstract] [Full Text] [Related]
31. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination. Cheng WF, Hung CF, Lin KY, Ling M, Juang J, He L, Lin CT, Wu TC. Gene Ther; 2003 Aug 10; 10(16):1311-20. PubMed ID: 12883527 [Abstract] [Full Text] [Related]
32. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N. J Immunol; 2009 Feb 15; 182(4):1799-809. PubMed ID: 19201831 [Abstract] [Full Text] [Related]
33. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors. Lee JM, Mahtabifard A, Yamada R, Crystal RG, Korst RJ. Clin Cancer Res; 2002 Nov 15; 8(11):3561-9. PubMed ID: 12429647 [Abstract] [Full Text] [Related]
34. West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II compartment, and enhanced neutralizing antibody response. Anwar A, Chandrasekaran A, Ng ML, Marques E, August JT. Virology; 2005 Feb 05; 332(1):66-77. PubMed ID: 15661141 [Abstract] [Full Text] [Related]
35. Immunization with plasmid DNA encoding MHC class II binding peptide/CLIP-replaced invariant chain (Ii) induces specific helper T cells in vivo: the assessment of Ii p31 and p41 isoforms as vehicles for immunization. Nagata T, Higashi T, Aoshi T, Suzuki M, Uchijima M, Koide Y. Vaccine; 2001 Oct 12; 20(1-2):105-14. PubMed ID: 11567753 [Abstract] [Full Text] [Related]
36. [Naked DNA vaccines]. Spitz M. Medicina (B Aires); 2000 Oct 12; 60(5 Pt 1):639-44. PubMed ID: 11188908 [Abstract] [Full Text] [Related]
37. Modulating the immune response to genetic immunization. Cohen AD, Boyer JD, Weiner DB. FASEB J; 1998 Dec 12; 12(15):1611-26. PubMed ID: 9837851 [Abstract] [Full Text] [Related]
38. Cytokine-FC fusion genes as molecular adjuvants for DNA vaccines. Hirschhorn-Cymerman D, Perales MA. Methods Mol Biol; 2010 Dec 12; 651():131-55. PubMed ID: 20686965 [Abstract] [Full Text] [Related]
39. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. Casares S, Inaba K, Brumeanu TD, Steinman RM, Bona CA. J Exp Med; 1997 Nov 03; 186(9):1481-6. PubMed ID: 9348305 [Abstract] [Full Text] [Related]
40. DNA vaccines: MHC II-targeted vaccine protein produced by transfected muscle fibres induces a local inflammatory cell infiltrate in mice. Løvås TO, Bruusgaard JC, Øynebråten I, Gundersen K, Bogen B. PLoS One; 2014 Nov 03; 9(10):e108069. PubMed ID: 25299691 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]